Phenotypic Correction of α-Sarcoglycan Deficiency by Intra-arterial Injection of a Muscle-specific Serotype 1 rAAV Vector
Open Access
- 31 January 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (1) , 53-61
- https://doi.org/10.1038/sj.mt.6300022
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Molecular and cell biology of the sarcoglycan complexMuscle & Nerve, 2005
- Muscles of mice deficient in α-sarcoglycan maintain large masses and near control force values throughout the life spanPhysiological Genomics, 2005
- Therapy Insight: cardiovascular complications associated with muscular dystrophiesNature Clinical Practice Cardiovascular Medicine, 2005
- Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting ProteinThe Journal of cell biology, 2000
- Sarcoglycan Isoforms in Skeletal MuscleJournal of Biological Chemistry, 1999
- Progressive Muscular Dystrophy in α-Sarcoglycan–deficient MiceThe Journal of cell biology, 1998
- Bidirectional Signaling between Sarcoglycans and the Integrin Adhesion System in Cultured L6 MyocytesPublished by Elsevier ,1998
- Primary adhalinopathy (α‐sarcoglycanopathy)Neurology, 1997
- Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophyCell, 1994
- Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscleNature, 1990